Progress in the field of probiotics: Year 2011

Current Opinion in Gastroenterology

Volumn 27, Issue 1, 2011, Pages 13-18

  Deshpande, Girish ^a,b   Rao, Shripad ^a,b,c   Patole, Sanjay ^a,b  

^a KEM Hospital for Women   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

Author keywords

Advances; Probiotics; Progress; Review

Indexed keywords

CHOLESTEROL; COPROSTEROL; IMMUNOGLOBULIN E; INTERLEUKIN 10; LACTOSE; PREBIOTIC AGENT; PROBIOTIC AGENT; VSL3;

ANTIBIOTIC RESISTANCE; ARTICLE; ATHEROSCLEROSIS; ATOPIC DERMATITIS; CHOLESTEROL BLOOD LEVEL; CONSTIPATION; CRITICALLY ILL PATIENT; DIARRHEA; ECZEMA; ENTERITIS; HALITOSIS; HEART DISEASE; HELICOBACTER INFECTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE CANCER; IRRITABLE COLON; LIVER CIRRHOSIS; METABOLIC DISORDER; NECROTIZING ENTEROCOLITIS; OBESITY; PERIODONTAL DISEASE; RANDOMIZED CONTROLLED TRIAL (TOPIC); ULCERATIVE COLITIS; VENTILATOR ASSOCIATED PNEUMONIA; VERY LOW BIRTH WEIGHT;

ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; PROBIOTICS;

EID: 79951680930     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e328341373e     Document Type: Article

References (60)

1. Williams NT. Probiotics. Am J Health Syst Pharm 2010; 67:449-458.
2. Antoine JM. Probiotics: Beneficial factors of the defence system. Proc Nutr Soc 2010; 69:429-433.
3. Ohland CL, Macnaughton WK. Probiotic bacteria and intestinal epithelial barrier function. Am J Physiol Gastrointest Liver Physiol 2010; 298:G807-G819. Review to understand the interactions between probiotic bacteria and the gut barrier.
4. Gó mez-Llorente C, Muń oz S, Gil A. Role of Toll-like receptors in the development of immunotolerance mediated by probiotics. Proc Nutr Soc 2010; 69:381-389. Review to understand the basic science of the interaction between probiotic bacteria and the Toll-like receptors.
5. Amit-Romach E, Uni Z, Reifen R. Multistep mechanism of probiotic bacterium, the effect on innate immune system. Mol Nutr Food Res 2010; 54:277-284.
6. Narayan SS, Jalgaonkar S, Shahani S, Kulkarni VN. Probiotics: Current trends in the treatment of diarrhoea. Hong Kong Med J 2010; 16:213-218.
7. Deshpande G, Rao S, Patole S, Bulsara M. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010; 125:921-930. Conclusive updated systematic review and meta-analysis with implications for change in practice.
8. Yan F, Polk DB. Probiotics: Progress toward novel therapies for intestinal diseases. Curr Opin Gastroenterol 2010; 26:95-101. Comprehensive review of probiotics as a novel therapy for intestinal diseases.
9. Kale-Pradhan PB, Jassal HK, Wilhelm SM. Role of Lactobacillus in the prevention of antibiotic-associated diarrhea: A meta-analysis. Pharmacotherapy 2010; 30:119-126. Systematic review of RCTs in antibiotic-associated diarrhoea in adults and children.
10. Chen F, Wang D. Novel technologies for the prevention and treatment of dental caries: A patent survey. Expert Opin Ther Pat 2010; 20:681-694.
11. Foster KJ, Lin S, Turck CJ. Current and emerging strategies for treating hepatic encephalopathy. Crit Care Nurs Clin North Am 2010; 22:341-350.
12. Lionetti E, Indrio F, Pavone L, et al. Role of probiotics in pediatric patients with Helicobacter pylori infection: A comprehensive review of the literature. Helicobacter 2010; 15:79-87.
13. Kataria J, Li N, Wynn JL, Neu J. Probiotic microbes: Do they need to be alive to be beneficial? Nutr Rev 2009; 67:546-550.
14. Awad H, Mokhtar H, Imam SS, et al. Comparison between killed and living probiotic usage versus placebo for the prevention of necrotizing enterocolitis and sepsis in neonates. Pak J Biol Sci 2010; 13:253-262.
15. Adams CA. The probiotic paradox: Live and dead cells are biological response modifiers. Nutr Res Rev 2010; 23:37-46.
16. Luoto R, Kalliomä ki M, Laitinen K, Isolauri E. The impact of perinatal probiotic intervention on the development of overweight and obesity: Follow-up study from birth to 10 years. Int J Obes (Lond) 2010. [Epub ahead of print]
17. Kalliomaki M, Salminen S, Arvilommi H, et al. Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet 2001; 357:1076-1079. (Pubitemid 32322538)
18. Kalliomaki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo controlled trial. J Allergy Clin Immunol 2007; 119:1019-1021; 15. (Pubitemid 46527807)
19. Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: A randomized controlled trial. J Allergy Clin Immunol 2007; 119:184-191. (Pubitemid 46037800)
20. Weston S, Halbert A, Richmond P, Prescott SL. Effects of probiotics on atopic dermatitis: A randomised controlled trial. Arch Dis Child 2005; 90:892-897. (Pubitemid 41232336)
21. Kim JY, Kwon JH, Ahn SH, et al. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: A double-blind, randomized, placebo-controlled trial. Pediatr Allergy Immunol 2010; 21 (2 Pt 2):e386-e393.
22. Guandalini S, Magazzù G, Chiaro A, et al. VSL3 improves symptoms in children with irritable bowel syndrome: A multicenter, randomized, placebocontrolled, double-blind, crossover study. J Pediatr Gastroenterol Nutr 2010; 51:24-30.
23. MacDonald TT, Bell I. Probiotics and the immune response to vaccines. Proc Nutr Soc 2010; 69:442-446. Review to understand the potential of probiotics as vaccine adjuvants.
24. Soh SE, Ong DQ, Gerez I, et al. Effect of probiotic supplementation in the first 6 months of life on specific antibody responses to infant Hepatitis B vaccination. Vaccine 2010; 28:2577-2579.
25. Van Overtvelt L, Moussu H, Horiot S, et al. Lactic acid bacteria as adjuvants for sublingual allergy vaccines. Vaccine 2010; 28:2986-2992.
26. Harata G, He F, Hiruta N, et al. Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responses. Lett Appl Microbiol 2010; 50:597-602.
27. Vintiń i E, Villena J, Alvarez S, Medina M. Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis-PppA induces effective protection against pneumoccocal infection in young mice. Clin Exp Immunol 2010; 159:351-362.
28. Collins MD, Gibson GR. Probiotics, prebiotics, and synbiotics: Approaches for modulating the microbial ecology of the gut. Am J Clin Nutr 1999; 69:1052S-1057S. (Pubitemid 29205084)
29. Bäckhed F, Ley RE, Sonnenburg JL, et al. Hostbacterial mutualism in the human intestine. Science 2005; 307:1915-1920.
30. Quigley EM. Prebiotics and probiotics; modifying and mining the microbiota. Pharmacol Res 2010; 61:213-218.
31. Vitali B, Ndagijimana M, Cruciani F, et al. Impact of a synbiotic food on the gut microbial ecology and metabolic profiles. BMC Microbiol 2010; 10:4.
32. De Regt MJ, Willems RJ, Hené RJ, et al. Effects of probiotics on acquisition and spread of multiresistant enterococci. Antimicrob Agents Chemother 2010; 54:2801-2805.
33. Vidal M, Forestier C, Charbonnel N, et al. Probiotics and intestinal colonization by vancomycin-resistant enterococci in mice and humans. J Clin Microbiol 2010; 48:2595-2598.
34. Hammad AM, Shimamoto T. Towards a compatible probiotic-antibiotic combination therapy: Assessment of antimicrobial resistance in the Japanese probiotics. J Appl Microbiol 2010. [Epub ahead of print]
35. De Moreno de Leblanc A, Perdigó n G. The application of probiotic fermented milks in cancer and intestinal inflammation. Proc Nutr Soc 2010; 69:421-428.
36. Shaukat A, Levitt MD, Taylor BC, et al. Systematic review: Effective management strategies for lactose intolerance. Ann Intern Med 2010; 152:797-803.
37. Sang LX, Chang B, Zhang WL, et al. Remission induction and maintenance effect of probiotics on ulcerative colitis: A meta-analysis. World J Gastroenterol 2010; 16:1908-1915.
38. Parkes GC, Sanderson JD, Whelan K. Treating irritable bowel syndrome with probiotics: The evidence. Proc Nutr Soc 2010; 69:187-194.
39. Moayyedi P, Ford AC, Talley NJ, et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: A systematic review. Gut 2010; 59:325-332. Systematic review evaluating effects of probiotics in IBS.
40. Sanz Y, Santacruz A, Gauffin P. Gut microbiota in obesity and metabolic disorders. Proc Nutr Soc 2010; 69:434-441. Comprehensive review for understanding the role of gut microbiota in obesity and metabolic disorders.
41. Musso G, Gambino R, Cassader M. Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: Mechanisms and implications for metabolic disorders. Curr Opin Lipidol 2010; 21:76-83. Comprehensive review for understanding the role of gut microbiota in obesity and metabolic disorders.
42. Morrow LE, Kollef MH, Casale TB. Probiotic prophylaxis of ventilator-associated pneumonia: A blinded, randomized, controlled trial. Am J Respir Crit Care Med 2010. [Epub ahead of print]
43. Siempos II, Vardakas KZ, Kopterides P, Falagas ME. Adjunctive therapies for community-acquired pneumonia: A systematic review. J Antimicrob Chemother 2008; 62:661-668.
44. Chmielewska A, Szajewska H. Systematic review of randomised controlled trials: Probiotics for functional constipation. World J Gastroenterol 2010; 16:69-75.
45. Huang Y, Wang J, Cheng Y, Zheng Y. The hypocholesterolaemic effects of Lactobacillus acidophilus American Type Culture Collection 4356 in rats are mediated by the down-regulation of Niemann-Pick C1-like 1. Br J Nutr 2010; 104:807-812.
46. Ramaswamy K, Abdullah N, Wong MC, et al. Bile salt deconjugation and cholesterol removal from media by Lactobacillus strains used as probiotics in chickens. J Sci Food Agric 2010; 90:65-69.
47. Lye HS, Rusul G, Liong MT. Removal of cholesterol by Lactobacilli via incorporation and conversion to coprostanol. J Dairy Sci 2010; 93:1383-1392.
48. Pereg D, Kotliroff A, Gadoth N, et al. Probiotics for patients with compensated liver cirrhosis: A double-blind placebo-controlled study. Nutrition 2010. [Epub ahead of print]
49. Besselink MG, van Santvoort HC, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: A randomised, double-blind, placebocontrolled trial. Lancet 2008; 371:651-659.
50. Barraud D, Blard C, Hein F, et al. Probiotics in the critically ill patient: A double blind, randomized, placebo-controlled trial. Intensive Care Med 2010. [Epub ahead of print] Latest RCT evaluating effects of probiotics in critically ill patients.
51. Flichy-Fernàndez AJ, Peń arrocha-Diago M. Probiotic treatment in the oral cavity: An update. Med Oral Patol Oral Cir Bucal 2010. [Epub ahead of print]
52. Arciero JC, Ermentrout GB, Upperman JS, et al. Using a mathematical model to analyze the role of probiotics and inflammation in necrotizing enterocolitis. PLoS One 2010; 5:e10066. Use of mathematical models as a novel tool to evaluate the role of probiotics in inflammatory bowel conditions like necrotizing enterocolitis.
53. Patel AK, Singhania RR, Pandey A, Chincholkar SB. Probiotic bile salt hydrolase: Current developments and perspectives. Appl Biochem Biotechnol 2010; 162:166-180.
54. Abe F, Muto M, Yaeshima T, et al. Safety evaluation of probiotic bifidobacteria by analysis of mucin degradation activity and translocation ability. Anaerobe 2010; 16:131-136.
55. Tiihonen K, Ouwehand AC, Rautonen N. Human intestinal microbiota and healthy ageing. Ageing Res Rev 2010; 9:107-116.
56. Jankovic I, Sybesma W, Phothiarath P, et al. Application of probiotics in food products: Challenges and new approaches. Curr Opin Biotechnol 2010; 21:175-181.
57. Possemiers S, Marzorati M, Verstraete W, et al. Bacteria and chocolate: A successful combination for probiotic delivery. Int J Food Microbiol 2010. [Epub ahead of print]
58. Weinbreck F, Bodnar I, Marco ML. Can encapsulation lengthen the shelf-life of probiotic bacteria in dry products? Int J Food Microbiol 2010; 136:364-367.
59. Matricardi PM. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Controversial aspects of the 'hygiene hypothesis'. Clin Exp Immunol 2010; 160:98-105.
60. Okada H, Kuhn C, Feillet H, Bach JF. The 'hygiene hypothesis' for autoimmune and allergic diseases: An update. Clin Exp Immunol 2010; 160:1-9.